<?xml version="1.0" encoding="UTF-8"?>
<results title="plant_compound">
 <result pre="Although the principal components of oregano and thyme EOs are" exact="carvacrol" post="and thymol, respectively, their chemical compositions vary depending on"/>
 <result pre="mostly attributable to the presence of phenolic compounds, such as" exact="carvacrol" post="and thymol [22,23,24]; however, other minor constituents such as"/>
 <result pre="to the presence of phenolic compounds, such as carvacrol and" exact="thymol" post="[22,23,24]; however, other minor constituents such as monoterpene hydrocarbons"/>
 <result pre="however, other minor constituents such as monoterpene hydrocarbons Î³-terpinene and" exact="p-cymene" post="contribute to the antibacterial activity of the oils as"/>
 <result pre="chemicals in both EOs. In EO extracted from O. vulgare," exact="carvacrol" post="was the predominant compound representing 77.92%/82.60% (= 13.52/15.01 mg/kg)"/>
 <result pre="columns, respectively. Other compounds detected in significantly lower amounts were" exact="p-cymene" post="and Î³-terpinene with percentage values 8.25%/5.63% (= 1.24/0.88 mg/kg)"/>
 <result pre="4.52%/3.33% (= 0.74/0.57 mg/kg). In EO obtained from T. vulgaris," exact="thymol" post="was the most abundant component representing 42.34%/48.46% (= 6.55/10.04"/>
 <result pre="most abundant component representing 42.34%/48.46% (= 6.55/10.04 mg/kg), followed by" exact="p-cymene" post="and Î³-terpinene representing 24.08%/18.00% (= 3.22/3.22 mg/kg) and 13.37%/10.61%"/>
 <result pre="this study, vapors of O. vulgare EO containing 92% of" exact="carvacrol" post="inhibited growth of S. aureus ATCC 25923 with MIC"/>
 <result pre="from 125 to 250 Î¼L/L. However, a thyme EO where" exact="thymol" post="was the predominant compound was not active at all."/>
 <result pre="was the most abundant compound in oregano EO, followed by" exact="p-cymene" post="and Î³-terpinene, and the oil is, thus, characterized as"/>
 <result pre="and Î³-terpinene, and the oil is, thus, characterized as a" exact="carvacrol" post="chemotype. This finding is in accordance with several previously"/>
 <result pre="Scalas et al. [60], and Stoilova et al. [61] reported" exact="carvacrol" post="as the main component of oregano EO (contributing 64.50%,"/>
 <result pre="EO (contributing 64.50%, 62.61%, and 66.20% of the EO, respectively)," exact="p-cymene" post="as the second the most abundant compound (10.90%; 12.36%,"/>
 <result pre="abundant constituent in thyme EO, also followed by its precursors," exact="p-cymene" post="and Î³-terpinene; therefore the present thyme oil belongs to"/>
 <result pre="p-cymene and Î³-terpinene; therefore the present thyme oil belongs to" exact="thymol" post="chemotype. This finding is also in accordance with numerous"/>
 <result pre="addition, it can avoid time-consuming procedures of calibration [71]. Since" exact="carvacrol" post="and thymol have been found to be the most"/>
 <result pre="can avoid time-consuming procedures of calibration [71]. Since carvacrol and" exact="thymol" post="have been found to be the most abundant compounds"/>
 <result pre="previous research [14], whereas the range of MIC values of" exact="carvacrol" post="(370â€&quot;1593 Î¼g/mL and 484â€&quot;1024 Î¼g/mL in agar and broth"/>
 <result pre="Î¼g/mL and 484â€&quot;1024 Î¼g/mL in agar and broth media) and" exact="thymol" post="(341â€&quot;1707 Î¼g/mL and 355â€&quot;1024 Î¼g/mL in the vapor and"/>
 <result pre="tested in this study. The occurrence of additive interaction between" exact="carvacrol" post="and thymol could be related to the similarity in"/>
 <result pre="this study. The occurrence of additive interaction between carvacrol and" exact="thymol" post="could be related to the similarity in their molecular"/>
 <result pre="are isomers), suggesting a similar mechanism of action [72]. Both" exact="thymol" post="and carvacrol are expected to cause functional and structural"/>
 <result pre="suggesting a similar mechanism of action [72]. Both thymol and" exact="carvacrol" post="are expected to cause functional and structural damages to"/>
 <result pre="the cytoplasmic membranes. The primary mechanism of antibacterial action of" exact="thymol" post="is not fully known; however, it is believed to"/>
 <result pre="and intracellular targets. Similarly, the primary mechanism of action of" exact="carvacrol" post="is its ability to position in the membrane where"/>
 <result pre="compounds, carvacrol, and thymol, were followed by their biosynthetic precursors" exact="p-cymene" post="and Î³-terpinene, which, together with the main compound comprised"/>
 <result pre="by Ultee et al. [74], who reported synergistic activity between" exact="carvacrol" post="and cymene against Bacillus cereus, or by Delgado et"/>
 <result pre="cymene was combined with thymol. The additive antimicrobial effect of" exact="carvacrol" post="and thymol has already been previously reported in several"/>
 <result pre="combined with thymol. The additive antimicrobial effect of carvacrol and" exact="thymol" post="has already been previously reported in several studies against"/>
 <result pre="the inhalation route. However, the data on their predominant compounds," exact="carvacrol" post="and thymol, might suggest their possible inhalation safety. The"/>
 <result pre="safety. The European Chemicals Agency reported that the LC50 of" exact="carvacrol" post="in rats was estimated to be greater than 20"/>
 <result pre="6 h exposure period. Similarly, the reported LC50 value for" exact="thymol" post="was 7.57 mg/L, when mice were exposed to a"/>
 <result pre="acute oral toxicity study, the median lethal dose (LD50) of" exact="carvacrol" post="and thymol in rats was found to be 810"/>
 <result pre="toxicity study, the median lethal dose (LD50) of carvacrol and" exact="thymol" post="in rats was found to be 810 and 980"/>
 <result pre="which means that it might be â€œharmful if swallowedâ€�. Moreover," exact="thymol" post="is FDA approved when used as a synthetic flavoring"/>
 <result pre="perfumes, food flavorings, mouthwashes, pharmaceutical preparations, and cosmetics [85]. Similarly," exact="carvacrol" post="is generally considered safe for human consumption. It has"/>
 <result pre="[87]. The above-mentioned data suggest a low toxicological risk of" exact="carvacrol" post="and thymol administration through an inhalation route. Moreover, the"/>
 <result pre="above-mentioned data suggest a low toxicological risk of carvacrol and" exact="thymol" post="administration through an inhalation route. Moreover, the rich historical"/>
 <result pre="Sigma-Aldrich (Prague, Czech Republic), whereas dimethylsulfoxide (DMSO, CAS: 67-68-5) and" exact="n-hexane" post="(CAS: 110-54-3) were obtained from Penta (Prague, Czech Republic)."/>
 <result pre="498-15-7), borneol (97%, CAS: 464-45-9), bornyl acetate (95%, CAS: 5655-61-8)," exact="camphene" post="(97.5%, CAS: 79-92-5), camphor (98%, CAS: 464-49-3), carvacrol (97%,"/>
 <result pre="CAS: 5655-61-8), camphene (97.5%, CAS: 79-92-5), camphor (98%, CAS: 464-49-3)," exact="carvacrol" post="(97%, CAS: 499-75-2), caryophyllene oxide (99%, CAS: 1139-30-6), linalool"/>
 <result pre="CAS: 79-92-5), camphor (98%, CAS: 464-49-3), carvacrol (97%, CAS: 499-75-2)," exact="caryophyllene" post="oxide (99%, CAS: 1139-30-6), linalool (97%, CAS: 78-70-6), p-cymene"/>
 <result pre="499-75-2), caryophyllene oxide (99%, CAS: 1139-30-6), linalool (97%, CAS: 78-70-6)," exact="p-cymene" post="(99%, CAS: 99-87-6), thymol (99%, CAS: 89-83-8), Î±-pinene (â‰¥99%,"/>
 <result pre="CAS: 1139-30-6), linalool (97%, CAS: 78-70-6), p-cymene (99%, CAS: 99-87-6)," exact="thymol" post="(99%, CAS: 89-83-8), Î±-pinene (â‰¥99%, CAS: 7785-70-8), Î±-terpinene (85%,"/>
 <result pre="isothermic period of 20 min. Both EOs were diluted in" exact="n-hexane" post="for GC/MS at a concentration of 20 Âµg/mL, and"/>
 <result pre="of 20 Âµg/mL, and for quantitative analysis, 1 Î¼L of" exact="methyl octanoate" post="was added as an internal standard. One Î¼L of"/>
 <result pre="(calculated from the molecular formulae of the component using a" exact="methyl octanoate" post="as internal standard), m MO â€&quot;mass of methyl octanoate"/>
 <result pre="a methyl octanoate as internal standard), m MO â€&quot;mass of" exact="methyl octanoate" post="(internal standard, IS), Ai and AMO are the peak"/>
 <result pre="A reviewPlanta Med.20208682285710.1055/a-1158-452932450573 14.NetopilovaM.HoudkovaM.RondevaldovaJ.KmetV.KokoskaL.Evaluation of in vitro growth-inhibitory effect of" exact="carvacrol" post="and thymol combination against Staphylococcus aureus in liquid and"/>
 <result pre="Med.20208682285710.1055/a-1158-452932450573 14.NetopilovaM.HoudkovaM.RondevaldovaJ.KmetV.KokoskaL.Evaluation of in vitro growth-inhibitory effect of carvacrol and" exact="thymol" post="combination against Staphylococcus aureus in liquid and vapour phase"/>
 <result pre="analysis and antibacterial activity of Thymus vulgaris chemotypes geraniol, 4-thujanol/terpinen-4-ol," exact="thymol" post="and linalool cultivated in southern FranceNat. Prod. Commun.201271095109810.1177/1934578X120070083322978238 27.JafriH.AhmadI.Thymus"/>
 <result pre="in southern FranceNat. Prod. Commun.201271095109810.1177/1934578X120070083322978238 27.JafriH.AhmadI.Thymus vulgaris essential oil and" exact="thymol" post="inhibit biofilms and interact synergistically with antifungal drugs against"/>
 <result pre="using the synergies of oregano and rosemary essential oils or" exact="carvacrol" post="and 1,8-cineoleFront Microbiol.20156122310.3389/fmicb.2015.0122326579115 33.van VuurenS.F.SulimanS.ViljoenA.M.The antimicrobial activity of four"/>
 <result pre="antioxidant and antibacterial activity of thyme and oregano essential oils," exact="thymol" post="and carvacrol and their possible synergismJ. Essent. Oil Bear.2015181013102110.1080/0972060X.2014.971069"/>
 <result pre="antibacterial activity of thyme and oregano essential oils, thymol and" exact="carvacrol" post="and their possible synergismJ. Essent. Oil Bear.2015181013102110.1080/0972060X.2014.971069 36.LopezP.SanchezC.BatlleR.NerinC.Vapor-phase activities"/>
 <result pre="ConceicaoM.L.NetoN.J.da CostaA.C.Combined application of Origanum vulgare l. essential oil and" exact="acetic acid" post="for controlling the growth of Staphylococcus aureus in foodsBraz."/>
 <result pre="phaseInd. Crops Prod.2009131909510.1016/j.indcrop.2019.01.036 58.ChoY.KimH.BeuchatL.R.RyuJ.-H.Synergistic activities of gaseous oregano and thyme" exact="thymol" post="essential oils against Listeria monocytogenes on surfaces of a"/>
 <result pre="and interactions with food matrix componentsFront. Microbiol.201231210.3389/fmicb.2012.0001222291693 74.UlteeA.SlumpR.A.StegingG.SmidE.J.Antimicrobial activity of" exact="carvacrol" post="toward Bacillus cereus on riceJ. Food Prot.20006362062410.4315/0362-028X-63.5.62010826719 75.DelgadoB.FernandezP.S.PalopA.PeriagoP.M.Effect of"/>
 <result pre="carvacrol toward Bacillus cereus on riceJ. Food Prot.20006362062410.4315/0362-028X-63.5.62010826719 75.DelgadoB.FernandezP.S.PalopA.PeriagoP.M.Effect of" exact="thymol" post="and cymene on Bacillus cereus vegetative cells evaluated through"/>
 <result pre="inhibitory concentration and mode of action of oregano essential oil," exact="thymol" post="and carvacrolJ. Appl. Microbiol.20019145346210.1046/j.1365-2672.2001.01428.x11556910 77.BurtS.A.VlielanderR.HaagsmanH.P.VeldhuizenE.J.Increase in activity of essential"/>
 <result pre="carvacrolJ. Appl. Microbiol.20019145346210.1046/j.1365-2672.2001.01428.x11556910 77.BurtS.A.VlielanderR.HaagsmanH.P.VeldhuizenE.J.Increase in activity of essential oil components" exact="carvacrol" post="and thymol against Escherichia coli O157:H7 by addition of"/>
 <result pre="Microbiol.20019145346210.1046/j.1365-2672.2001.01428.x11556910 77.BurtS.A.VlielanderR.HaagsmanH.P.VeldhuizenE.J.Increase in activity of essential oil components carvacrol and" exact="thymol" post="against Escherichia coli O157:H7 by addition of food stabilizersJ."/>
 <result pre="online: https://echa.europa.eu/(accessed on 15 October 2020) 84.XieK.TashkinD.P.LuoM.Z.ZhangJ.Y.Chronic toxicity of inhaled" exact="thymol" post="in lungs and respiratory tracts in mouse modelPharmacol. Res."/>
 <result pre="(calculated from the molecular formulae of the component using a" exact="methyl octanoate" post="as internal standard); 4 Column = composition of essential"/>
 <result pre="0.10 0.24 0.05 GC/MS, RI GC/MS 12 1090 a 1086" exact="Isoterpinolene" post="MH 0.765 0.18 0.03 - - GC/MS, RI -"/>
 <result pre="(calculated from the molecular formulae of the component using a" exact="methyl octanoate" post="as internal standard); 4 Column = composition of essential"/>
</results>
